CN1205941C - 葛根素口服制剂及其制备方法 - Google Patents
葛根素口服制剂及其制备方法 Download PDFInfo
- Publication number
- CN1205941C CN1205941C CN02135329.8A CN02135329A CN1205941C CN 1205941 C CN1205941 C CN 1205941C CN 02135329 A CN02135329 A CN 02135329A CN 1205941 C CN1205941 C CN 1205941C
- Authority
- CN
- China
- Prior art keywords
- puerarin
- parts
- preparation
- capsule
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 title claims abstract description 165
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 title claims abstract description 165
- 238000002360 preparation method Methods 0.000 title claims abstract description 47
- 239000008187 granular material Substances 0.000 claims abstract description 46
- 239000002775 capsule Substances 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 14
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 58
- 239000000203 mixture Substances 0.000 claims description 55
- 229910019142 PO4 Inorganic materials 0.000 claims description 28
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 28
- 239000010452 phosphate Substances 0.000 claims description 28
- 238000002156 mixing Methods 0.000 claims description 27
- 229920000159 gelatin Polymers 0.000 claims description 25
- 235000019322 gelatine Nutrition 0.000 claims description 25
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 23
- 239000001828 Gelatine Substances 0.000 claims description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 15
- 239000007901 soft capsule Substances 0.000 claims description 15
- 239000006188 syrup Substances 0.000 claims description 15
- 235000020357 syrup Nutrition 0.000 claims description 15
- 238000001291 vacuum drying Methods 0.000 claims description 14
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 13
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 13
- 229920002472 Starch Polymers 0.000 claims description 13
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 13
- 239000008101 lactose Substances 0.000 claims description 13
- 239000000741 silica gel Substances 0.000 claims description 13
- 229910002027 silica gel Inorganic materials 0.000 claims description 13
- 229940083466 soybean lecithin Drugs 0.000 claims description 13
- 239000008107 starch Substances 0.000 claims description 13
- 235000019698 starch Nutrition 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- 206010013786 Dry skin Diseases 0.000 claims description 9
- 238000012856 packing Methods 0.000 claims description 9
- 239000007779 soft material Substances 0.000 claims description 9
- 239000007902 hard capsule Substances 0.000 claims description 7
- 150000003904 phospholipids Chemical class 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 238000005096 rolling process Methods 0.000 claims description 7
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical group [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 230000002745 absorbent Effects 0.000 claims description 2
- 239000002250 absorbent Substances 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 239000004411 aluminium Substances 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 210000004681 ovum Anatomy 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 11
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract description 4
- 229920000053 polysorbate 80 Polymers 0.000 abstract description 4
- 229940079593 drug Drugs 0.000 abstract description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 230000035699 permeability Effects 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 abstract 2
- 229940068968 polysorbate 80 Drugs 0.000 abstract 2
- 230000007794 irritation Effects 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 229920000136 polysorbate Polymers 0.000 abstract 1
- 229950008882 polysorbate Drugs 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 229960004756 ethanol Drugs 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- 229960000935 dehydrated alcohol Drugs 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 7
- 239000007791 liquid phase Substances 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 235000010575 Pueraria lobata Nutrition 0.000 description 2
- 244000046146 Pueraria lobata Species 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN02135329.8A CN1205941C (zh) | 2002-07-31 | 2002-07-31 | 葛根素口服制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN02135329.8A CN1205941C (zh) | 2002-07-31 | 2002-07-31 | 葛根素口服制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1394609A CN1394609A (zh) | 2003-02-05 |
CN1205941C true CN1205941C (zh) | 2005-06-15 |
Family
ID=4748138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN02135329.8A Expired - Lifetime CN1205941C (zh) | 2002-07-31 | 2002-07-31 | 葛根素口服制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1205941C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100540009C (zh) * | 2006-02-23 | 2009-09-16 | 香港赛马会中药研究院有限公司 | 口服葛根素磷脂复合物胶囊及其制备方法 |
CN101288677B (zh) * | 2007-04-17 | 2011-01-12 | 普尔药物科技开发(深圳)有限公司 | 葛根素衍生物粉针剂及其制备方法 |
CN104940189B (zh) * | 2014-08-31 | 2019-01-11 | 北京罗诺强施医药技术研发中心有限公司 | 治疗增生病的组合物 |
CN104666391B (zh) * | 2015-03-10 | 2018-10-30 | 沈阳东新药业有限公司 | 柿叶总黄酮固体分散体滴丸及其制备方法 |
CN104940654A (zh) * | 2015-06-24 | 2015-09-30 | 黄红林 | 一种葛根胶囊 |
CN104940190A (zh) * | 2015-07-13 | 2015-09-30 | 江苏天晟药业有限公司 | 葛根素在制备镇痛药物中的应用 |
-
2002
- 2002-07-31 CN CN02135329.8A patent/CN1205941C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1394609A (zh) | 2003-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1091368C (zh) | 含辅酶q10的药学组合物 | |
CN1219390A (zh) | 新的用于控制和治疗肛门直肠和结肠疾病的药物组合物 | |
CN1205941C (zh) | 葛根素口服制剂及其制备方法 | |
CN101417070B (zh) | 用于治疗便秘的药物组合物及其制备方法 | |
CN101002816A (zh) | 一种淫羊藿总黄酮环糊精或环糊精衍生物的包合物及其制剂和制备方法 | |
CN100477997C (zh) | 含有三七总皂苷磷脂复合物的疏水性制剂及其制备方法 | |
CN1250277C (zh) | 一种具抗炎、镇痛、抑菌、利尿作用的药物 | |
CN1709454A (zh) | 一种治疗痛风的中药制剂及其制备方法 | |
CN101125154B (zh) | 泰山白首乌苷颗粒制剂及其制备方法 | |
CN1312157C (zh) | 卤代二氢青蒿素及其制备方法以及用途 | |
CN1872852A (zh) | 小檗碱衍生物及其制备方法和其药物组合物与用途 | |
CN102085376A (zh) | 龙胆总苷磷脂复合物及其制备方法 | |
CN1220510C (zh) | 一种益气补血养心安神的中成药及其制备方法质量控制方法 | |
CN101391076A (zh) | 一种治疗糖尿病的灰蔸巴提取物中药复合制剂 | |
CN112843009B (zh) | 一种制备根皮苷混合降糖制剂的方法 | |
CN1679703A (zh) | 一种由三七、银杏叶制成的治疗心脑血管疾病的药物制剂及其制备方法 | |
CN1449753A (zh) | 绿原酸、异绿原酸的组合物及它的医学用途 | |
CN1294948C (zh) | 一种益气健脾滋补肝肾的药物及其制备方法 | |
CN1861081A (zh) | 商陆皂苷甲在制备防治乳腺增生药物的新用途 | |
CN1569147A (zh) | 昆明山海棠巴布剂及其制备方法 | |
CN1537541A (zh) | 蒙脱石在制药中的应用 | |
CN103055080A (zh) | 用于消化道疾病的口服固体制剂 | |
CN1513465A (zh) | 一种葛根总黄酮口服制剂的制备方法及其葛根总黄酮口服制剂 | |
CN113599375A (zh) | 一种治疗口腔疾病的经口给药药物及用途 | |
CN1583139A (zh) | 一种血竭磷脂复合物的制备 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG ZIBO XINDA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANDONG UNIV. Effective date: 20090717 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090717 Address after: No. 1, Tai Mo Road, Zibo hi tech Development Zone, Shandong Patentee after: SHANDONG ZIBO XINCAT PHARMACEUTICAL Co.,Ltd. Address before: No. 44, Wenhua West Road, Lixia District, Shandong, Ji'nan Patentee before: Shandong University |
|
CX01 | Expiry of patent term |
Granted publication date: 20050615 |
|
CX01 | Expiry of patent term | ||
DD01 | Delivery of document by public notice |
Addressee: Jia Faqiang Document name: Notice of Patent Expiration and Termination |
|
DD01 | Delivery of document by public notice |